BioNTech Lung Cancer Drug Extends Survival Versus Chemotherapy
The experimental drug gotistobart nearly doubles median survival for patients with an aggressive form of lung cancer compared to chemotherapy.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- BioNTech